Tot Beheer Van Volksvermogen NV

Equities

094779003

BE0947790037

Real-time Euronext Bruxelles Other stock markets 06:30:00 2024-03-12 am EDT			5-day change	1st Jan Change
1,060 ^EUR	+20.45%		-.--%	+20.45%

2021	Thermo Fisher Scientific Inc. acquired PharmaFluidics NV	CI
2018	PharmaFluidics NV announced that it has received €7.3 million in funding from QBIC Venture Partners, Federal Holding and Investment Company, Theodorus, Tot Beheer Van Volksvermogen NV	CI

Thermo Fisher Scientific Inc. acquired PharmaFluidics NV

November 31, 2021

Thermo Fisher Scientific Inc. (NYSE:TMO) acquired PharmaFluidics NV on November 1, 2021. The µPAC portfolio acquisition complements Thermo Fisher's existing chromatography solutions to deliver extended analytical capabilities to researchers.

Thermo Fisher Scientific Inc. (NYSE:TMO) completed the acquisition of PharmaFluidics NV on November 1, 2021.

Latest news about Tot Beheer Van Volksvermogen NV

Thermo Fisher Scientific Inc. acquired PharmaFluidics NV	21-10-31	CI
PharmaFluidics NV announced that it has received €7.3 million in funding from QBIC Venture Partners, Federal Holding and Investment Company, Theodorus, Tot Beheer Van Volksvermogen NV	18-01-10	CI
Tot Beheer Van Volksvermogen NV and an undisclosed buyer acquired 20% stake in VDK Spaarbank N.V. for €40 million.	16-12-01	CI

Chart Tot Beheer Van Volksvermogen NV

Duration

Period

More charts

Company Profile

Sector

More about the company